pubmed-article:12886128 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12886128 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
pubmed-article:12886128 | lifeskim:mentions | umls-concept:C1514821 | lld:lifeskim |
pubmed-article:12886128 | lifeskim:mentions | umls-concept:C0040405 | lld:lifeskim |
pubmed-article:12886128 | lifeskim:mentions | umls-concept:C0184511 | lld:lifeskim |
pubmed-article:12886128 | lifeskim:mentions | umls-concept:C0332305 | lld:lifeskim |
pubmed-article:12886128 | lifeskim:mentions | umls-concept:C0040395 | lld:lifeskim |
pubmed-article:12886128 | lifeskim:mentions | umls-concept:C0205483 | lld:lifeskim |
pubmed-article:12886128 | lifeskim:mentions | umls-concept:C0233929 | lld:lifeskim |
pubmed-article:12886128 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:12886128 | pubmed:dateCreated | 2003-7-29 | lld:pubmed |
pubmed-article:12886128 | pubmed:abstractText | To determine if volumetric nonlinear registration or registration of thoracic computed tomography (CT) and 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) datasets changes the detection of mediastinal and hilar nodal disease in patients undergoing staging for lung cancer and if it has any impact on radiologic lung cancer staging. | lld:pubmed |
pubmed-article:12886128 | pubmed:language | eng | lld:pubmed |
pubmed-article:12886128 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12886128 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12886128 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12886128 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12886128 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12886128 | pubmed:issn | 0363-8715 | lld:pubmed |
pubmed-article:12886128 | pubmed:author | pubmed-author:AlpertNathani... | lld:pubmed |
pubmed-article:12886128 | pubmed:author | pubmed-author:FischmanAlan... | lld:pubmed |
pubmed-article:12886128 | pubmed:author | pubmed-author:AquinoSuzanne... | lld:pubmed |
pubmed-article:12886128 | pubmed:author | pubmed-author:HalpernElkan... | lld:pubmed |
pubmed-article:12886128 | pubmed:author | pubmed-author:AsmuthJane... | lld:pubmed |
pubmed-article:12886128 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12886128 | pubmed:volume | 27 | lld:pubmed |
pubmed-article:12886128 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12886128 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12886128 | pubmed:pagination | 479-84 | lld:pubmed |
pubmed-article:12886128 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:meshHeading | pubmed-meshheading:12886128... | lld:pubmed |
pubmed-article:12886128 | pubmed:articleTitle | Improved radiologic staging of lung cancer with 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography registration. | lld:pubmed |
pubmed-article:12886128 | pubmed:affiliation | Department of Radiology, FND 202, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. | lld:pubmed |
pubmed-article:12886128 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12886128 | pubmed:publicationType | Clinical Trial | lld:pubmed |